Shared Proteins and Pathways of Cardiovascular and Cognitive Diseases: Relation to Vascular Cognitive Impairment

Melisa E Zeylan1, Simge Senyuz1, Pol Picón-Pagès2

  • 1Computational Sciences and Engineering, Graduate School of Science and Engineering, Koç University, Istanbul 34450, Türkiye.

PubMed

Insights

Systems biology identified key proteins and pathways in vascular cognitive impairment (VCI). Oxidative and glycative stress, linked to aging, are implicated in VCI pathogenesis, involving advanced glycation end-products (AGEs) and RAGE signaling.

Area of Science:

  • Systems biology and computational approaches
  • Neuroscience and cardiovascular research
  • Aging and disease mechanisms

Background:

  • Vascular cognitive impairment (VCI) presents as cognitive decline due to vascular factors, with unclear underlying mechanisms.
  • Aging is a major VCI determinant, often involving oxidative stress.
  • Understanding VCI requires investigating the interplay between cardiovascular health and cognitive function.

Purpose of the Study:

  • To identify proteins and pathways associated with VCI using systems biology.
  • To explore the crosstalk between cardiovascular and cognitive diseases in VCI.
  • To investigate the role of oxidative and glycative stress in VCI etiology.

Main Methods:

  • Application of systems biology and computational analysis.
  • Prioritization of genes and proteins involved in VCI.
  • Enrichment analysis of identified genes/proteins in oxidative stress pathways.
  • Experimental validation of glycative stress and signaling pathways.

Main Results:

  • Oxidative stress pathways are highly relevant to VCI, with prioritized genes enriched in these pathways.
  • A list of potential VCI-contributing proteins was identified: DOLK, TSC1, ATP1A1, MAPK14, YWHAZ, CREB3, HSPB1, PRDX6, and LMNA.
  • Experimental data indicate glycative stress, advanced glycation end-products (AGEs), and RAGE signaling contribute to VCI.

Conclusions:

  • Oxidative and glycative stress are key contributors to VCI.
  • AGEs, RAGE, and Notch signaling are implicated in the etiology of VCI.
  • Identified proteins offer potential targets for VCI research and therapeutic strategies.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
31
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
159
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
93
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K